De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Trans Recip
Conditions:   Kidney Transplant; Complications;   CMV Interventions:   Drug: Letermovir 480 mg once daily;   Other: Historical/Control Sponsors:   Virginia Commonwealth University;   Merck Sharp & Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Donor Derived Cell-free DNA and Rejection of Kidney Allografts
Condition:   Kidney Rejection Transplant Intervention:   Diagnostic Test: Donor-derived cell-free DNA Sponsor:   Paris Translational Research Center for Organ Transplantation Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2023 Category: Research Source Type: clinical trials